ETHZilla Corp. Enters Material Definitive Agreement

Ticker: FRMM · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1690080

Ethzilla CORP 8-K Filing Summary
FieldDetail
CompanyEthzilla CORP (FRMM)
Form Type8-K
Filed DateSep 8, 2025
Risk Levelmedium
Pages6
Reading Time8 min
Key Dollar Amounts$0.0001, $80.0 million, $125.0 million, $250.0 million, $2.50
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, financial-obligation, corporate-name-change

Related Tickers: ETHZ

TL;DR

ETHZilla Corp. just signed a big deal, creating a new financial obligation. Keep an eye on this.

AI Summary

On September 5, 2025, ETHZilla Corp. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as 180 Life Sciences Corp. and KBL Merger Corp. IV, is involved in the pharmaceutical preparations industry.

Why It Matters

This filing indicates a significant new financial commitment or obligation for ETHZilla Corp., which could impact its future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements and creating financial obligations can introduce new risks related to the terms of the agreement and the company's ability to meet them.

Key Players & Entities

FAQ

What type of material definitive agreement did ETHZilla Corp. enter into?

The filing states that ETHZilla Corp. entered into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.

What is the nature of the direct financial obligation created?

The filing indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not detailed in this summary.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on September 5, 2025.

What were ETHZilla Corp.'s previous names?

ETHZilla Corp. was formerly known as 180 Life Sciences Corp. and KBL Merger Corp. IV.

What industry is ETHZilla Corp. primarily involved in?

ETHZilla Corp. is primarily involved in the Pharmaceutical Preparations industry, with SIC code 2834.

Filing Stats: 1,926 words · 8 min read · ~6 pages · Grade level 13.3 · Accepted 2025-09-08 09:29:54

Key Financial Figures

Filing Documents

01 Entry into a Material Definitive

Item 1.01 Entry into a Material Definitive Agreement. Amended and Restated Asset Management Agreement On September 5, 2025, ETHZilla Corporation (the " Company ", " we " and " us ") entered into an Amended and Restated Asset Management Agreement (the "A &R Asset Management Agreement "), which amended and restated that certain Asset Management Agreement (the " Original Asset Management Agreement "), dated as of August 4, 2025, with Electric Treasury Edge, LLC (the " Asset Manager "). The Original Asset Management Agreement was previously disclosed and described in the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 30, 2025 and such disclosure is incorporated herein by reference. The A&R Asset Management Agreement makes certain changes to the Original Asset Management Agreement, including, among other things, the expansion of to expand the scope of account assets and advisory services provided by the Asset Manager. The foregoing summary of the A&R Asset Management Agreement does not purport to be complete and is qualified in its entirety by the complete text of the A&R Asset Management Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. Transaction Agreement On September 8, 2025, 180 SPV Treasury Vehicle I LLC, a wholly-owned subsidiary of the Company (" 180 SPV "), entered into A Physically-Settled Spot and Forward Transaction Agreement (the " Transaction Agreement ") with Cumberland DRW LLC (" Counterparty "), to obtain up to $80.0 million from Counterparty pursuant to the terms of the Transaction Agreement. The Transaction Agreement has a forward rate of 9.90% per annum through the settlement date, which is December 8, 2025 (the " Settlement Date "). The transaction is expected to be collateralized by approximately $125.0 million of ETH. The proceeds from the Transaction Agreement are expected to be used by the Company to fund repurchases under t

03 Creation of a Direct Financial

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth above in Item 1.01 of this Current Report with respect to the Transaction Agreement is hereby incorporated by reference into this Item 2.03 .

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On September 8, 2025, the Company issued a press release announcing the execution of the Transaction Agreement and providing an update on its stock repurchase program and ETH accumulation, a copy of which is furnished hereto as Exhibit 99.1 , which is incorporated by reference into this Item 7.01 in its entirety. The information in this Item 7.01 of this Current Report on Form 8-K, including the information contained in Exhibit 99.1 is being furnished to the U.S. Securities and Exchange Commission, and shall not be deemed to be "filed" for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing. 1

01 Other Events

Item 8.01 Other Events. Stock Repurchase Program On August 22, 2025, the Board of Directors of the Company authorized and approved a stock repurchase program for up to $250.0 million of the currently outstanding shares of the Company's common stock. Subject to any future extension in the discretion of the Board of Directors of the Company, the repurchase program is scheduled to expire upon the earliest of (i) June 30, 2026, (ii) when a maximum of $250.0 million of the Company's common stock has been repurchased, or (iii) when such program is discontinued by the Board of Directors. On September 5, 2025, the Company repurchased an aggregate of 2,200,723 shares of common stock at an average price of $2.50 per share, which are in the process of being cancelled. ETH Accumulation Status Update A summary of ETHZilla's current ETH position and key metrics as of September 7, 2025, except for shares outstanding, as reduced by the shares repurchased by the Company on September 5, 2025 as discussed above: Total ETH & ETH Equivalents Held (1) : 102,246 Total ETH & ETH Equivalents Held (USD): approximately $443 million Total USD Cash Equivalents: approximately (2) : $213 million Total Shares Outstanding: 164,426,122 (1) Total ETH & ETH Equivalents Held includes ETH the Company has entered into agreement(s) to purchase. (2) Total USD Cash Equivalents excludes USD committed pursuant to agreement(s) to acquire ETH included in the Total ETH & ETH Equivalents Held. Does not include the proceeds from the Transaction Agreement discussed above. Additional Risk Factor In connection with the announcement of the Transaction Agreement, the Company is supplementing the risk factors previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2024 (the " Form 10-K "), as further updated with Risk Factors included in any subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (collectively, the " SEC Reports "), with the

Forward Looking Statements

Forward Looking Statements This Current Report on Form 8-K and the press release attached as Exhibit 99.1 to this Current Report on Form 8-K, may contain forward-looking information within the meaning of applicable securities laws (" forward-looking statements "). These forward-looking statements represent the Company's current expectations or beliefs concerning future events and can generally be identified using statements that include words such as "estimate," "expects," "project," "believe," "anticipate," "intend," "plan," "foresee," "forecast," "likely," "will," "target" or similar words or phrases. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of the Company's control which could cause actual results to differ materially from the results expressed or implied in the forward-looking repurchases under the repurchase program. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to the fact that common share repurchases may not be conducted in the timeframe or in the manner the Company expects, or at all. The Company undertakes no obligation to publicly update or revise any of the forward-looking statements, whether because of new information, future events or otherwise, made in the release or presentation or in any of its Securities and Exchange Commission (SEC) filings or public disclosures, except as provided by law. Consequently, you should not consider any such list to be a complete set of all potential risks and uncertainties. More information

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 8 , 2025 ETHZilla Corporation By: /s/ McAndrew Rudisill Name: McAndrew Rudisill Title: Chief Executive Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing